184 related articles for article (PubMed ID: 28648477)
1. Time to antibiotics administration and outcome in community-acquired pneumonia: Secondary analysis of a randomized controlled trial.
Marti C; John G; Genné D; Prendki V; Rutschmann OT; Stirnemann J; Garin N
Eur J Intern Med; 2017 Sep; 43():58-61. PubMed ID: 28648477
[TBL] [Abstract][Full Text] [Related]
2. β-Lactam monotherapy vs β-lactam-macrolide combination treatment in moderately severe community-acquired pneumonia: a randomized noninferiority trial.
Garin N; Genné D; Carballo S; Chuard C; Eich G; Hugli O; Lamy O; Nendaz M; Petignat PA; Perneger T; Rutschmann O; Seravalli L; Harbarth S; Perrier A
JAMA Intern Med; 2014 Dec; 174(12):1894-901. PubMed ID: 25286173
[TBL] [Abstract][Full Text] [Related]
3. Broad- versus Narrow-Spectrum Oral Antibiotic Transition and Outcomes in Health Care-associated Pneumonia.
Buckel WR; Stenehjem E; Sorensen J; Dean N; Webb B
Ann Am Thorac Soc; 2017 Feb; 14(2):200-205. PubMed ID: 27690519
[TBL] [Abstract][Full Text] [Related]
4. Empirical prescribing of penicillin G/V reduces risk of readmission of hospitalized patients with community-acquired pneumonia in Norway: a retrospective observational study.
Høgli JU; Garcia BH; Svendsen K; Skogen V; Småbrekke L
BMC Pulm Med; 2020 Jun; 20(1):169. PubMed ID: 32539706
[TBL] [Abstract][Full Text] [Related]
5. Prognostic factors in hospitalized community-acquired pneumonia: a retrospective study of a prospective observational cohort.
Ito A; Ishida T; Tokumasu H; Washio Y; Yamazaki A; Ito Y; Tachibana H
BMC Pulm Med; 2017 May; 17(1):78. PubMed ID: 28464807
[TBL] [Abstract][Full Text] [Related]
6. Predictors and Implications of Early Clinical Stability in Patients Hospitalized for Moderately Severe Community-Acquired Pneumonia.
Garin N; Felix G; Chuard C; Genné D; Carballo S; Hugli O; Lamy O; Marti C; Nendaz M; Rutschmann O; Harbarth S; Perrier A
PLoS One; 2016; 11(6):e0157350. PubMed ID: 27305046
[TBL] [Abstract][Full Text] [Related]
7. Azithromycin monotherapy for patients hospitalized with community-acquired pneumonia: a 31/2-year experience from a veterans affairs hospital.
Feldman RB; Rhew DC; Wong JY; Charles RA; Goetz MB;
Arch Intern Med; 2003 Jul; 163(14):1718-26. PubMed ID: 12885688
[TBL] [Abstract][Full Text] [Related]
8. Severe community-acquired pneumonia in general medical wards: outcomes and impact of initial antibiotic selection.
Wongsurakiat P; Chitwarakorn N
BMC Pulm Med; 2019 Oct; 19(1):179. PubMed ID: 31619219
[TBL] [Abstract][Full Text] [Related]
9. Duration of Antibiotic Treatment in Community-Acquired Pneumonia: A Multicenter Randomized Clinical Trial.
Uranga A; España PP; Bilbao A; Quintana JM; Arriaga I; Intxausti M; Lobo JL; Tomás L; Camino J; Nuñez J; Capelastegui A
JAMA Intern Med; 2016 Sep; 176(9):1257-65. PubMed ID: 27455166
[TBL] [Abstract][Full Text] [Related]
10. Guideline-concordant antibiotic use and survival among patients with community-acquired pneumonia admitted to the intensive care unit.
Frei CR; Attridge RT; Mortensen EM; Restrepo MI; Yu Y; Oramasionwu CU; Ruiz JL; Burgess DS
Clin Ther; 2010 Feb; 32(2):293-9. PubMed ID: 20206787
[TBL] [Abstract][Full Text] [Related]
11. Trimethylamine-N-oxide (TMAO) predicts fatal outcomes in community-acquired pneumonia patients without evident coronary artery disease.
Ottiger M; Nickler M; Steuer C; Odermatt J; Huber A; Christ-Crain M; Henzen C; Hoess C; Thomann R; Zimmerli W; Mueller B; Schuetz P
Eur J Intern Med; 2016 Dec; 36():67-73. PubMed ID: 27567042
[TBL] [Abstract][Full Text] [Related]
12. Community-acquired pneumonia and survival of critically ill acute exacerbation of COPD patients in respiratory intensive care units.
Lu Z; Cheng Y; Tu X; Chen L; Chen H; Yang J; Wang J; Zhang L
Int J Chron Obstruct Pulmon Dis; 2016; 11():1867-72. PubMed ID: 27563239
[TBL] [Abstract][Full Text] [Related]
13. Association Between Initial Route of Fluoroquinolone Administration and Outcomes in Patients Hospitalized for Community-acquired Pneumonia.
Belforti RK; Lagu T; Haessler S; Lindenauer PK; Pekow PS; Priya A; Zilberberg MD; Skiest D; Higgins TL; Stefan MS; Rothberg MB
Clin Infect Dis; 2016 Jul; 63(1):1-9. PubMed ID: 27048748
[TBL] [Abstract][Full Text] [Related]
14. Effect of corticosteroids on treatment failure among hospitalized patients with severe community-acquired pneumonia and high inflammatory response: a randomized clinical trial.
Torres A; Sibila O; Ferrer M; Polverino E; Menendez R; Mensa J; Gabarrús A; Sellarés J; Restrepo MI; Anzueto A; Niederman MS; Agustí C
JAMA; 2015 Feb; 313(7):677-86. PubMed ID: 25688779
[TBL] [Abstract][Full Text] [Related]
15. Misdiagnosis of community-acquired pneumonia and inappropriate utilization of antibiotics: side effects of the 4-h antibiotic administration rule.
Kanwar M; Brar N; Khatib R; Fakih MG
Chest; 2007 Jun; 131(6):1865-9. PubMed ID: 17400668
[TBL] [Abstract][Full Text] [Related]
16. Improving care for critically ill patients with community-acquired pneumonia.
Bianchini ML; Mercuro NJ; Kenney RM; Peters MA; Samuel LP; Swiderek J; Davis SL
Am J Health Syst Pharm; 2019 Jun; 76(12):861-868. PubMed ID: 31361849
[TBL] [Abstract][Full Text] [Related]
17. Timing of antibiotic administration and outcomes for Medicare patients hospitalized with community-acquired pneumonia.
Houck PM; Bratzler DW; Nsa W; Ma A; Bartlett JG
Arch Intern Med; 2004 Mar; 164(6):637-44. PubMed ID: 15037492
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of exclusively oral antibiotic therapy in patients hospitalized with nonsevere community-acquired pneumonia: a retrospective study and meta-analysis.
Marras TK; Nopmaneejumruslers C; Chan CK
Am J Med; 2004 Mar; 116(6):385-93. PubMed ID: 15006587
[TBL] [Abstract][Full Text] [Related]
19. Impact of Antibiotic Choice on Pneumonia Readmission Rates.
Hemenway AN; Naretta MA
Am J Ther; 2017; 24(4):e419-e422. PubMed ID: 26485359
[TBL] [Abstract][Full Text] [Related]
20. Can an antimicrobial stewardship program reduce length of stay of immune-competent adult patients admitted to hospital with diagnosis of community-acquired pneumonia? Study protocol for pragmatic controlled non-randomized clinical study.
DiDiodato G; McArthur L; Beyene J; Smieja M; Thabane L
Trials; 2015 Aug; 16():355. PubMed ID: 26272324
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
